ENZON PHARMACEUTICALS
About Enzon
Technology Platforms
Research & Development
Marketed Products
Partnering
Newsroom
Investors
Careers
Contact Us


ENZON HEADER PIC
Home > Investors
Analyst Coverage Annual Reports Press Releases SEC Filings
Request Information Calendar of Events E-mail Alerts Stock Quote Stock Lookup Corporate Governance Contact Us
Committee Composition
Print Print page     Email Email page

Committee Chair = Chair Committee Member = Member
  Governance and Nominating Committes Finance and Audit Compensation
Victor Micati Committee Chair for Governance and Nominating Committes Committee   Member of Compensation Committee
Robert LeBuhn Member of Governance and Nominating Committes Committee Member of Finance and Audit Committee  
Phillip M. Renfro Member of Governance and Nominating Committes Committee Member of Finance and Audit Committee  
Robert Salisbury Member of Governance and Nominating Committes Committee Committee Chair for Finance and Audit Committee  
Rolf A. Classon   Member of Finance and Audit Committee Member of Compensation Committee
Goran Ando     Committee Chair for Compensation Committee
 

 

 

Stock Information
(ENZN) NASD
Last Trade 9.310
Change(%) - 0.14
Volume 372,100
May 13, 2008 4:12 PM ET
New Product Release
Lab Look
Our four proprietary marketed brands are ABELCET®, ADAGEN®, DEPOCYT®, and ONCASPAR®. To learn more about our recent product releases CLICK HERE
Shareholder Tools
  • Briefcase Shareholder Briefcase
  • Printed Materials Printed Materials
  • Email Alerts Email Alerts
  • Download Center Download Library
  • Glossary Glossary
  • RSS RSS News Feeds

  • Search Investor Relations


Copyright © 2005-2007 Enzon Pharmaceuticals, Inc. All rights reserved.
Terms of Use
Privacy Information